What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide this
In women who have genitourinary syndrome of menopause, vaginal estrogens reduce symptoms and do not cause side effects
Rahn DD, Carberry C, Sanses TV, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol. 2014;124:1147-56.
In postmenopausal women who have genitourinary syndrome of menopause, do vaginal estrogens reduce symptoms? Do they cause side effects?
Genitourinary syndrome of menopause is a group of signs and symptoms that can affect the genital system (vaginal dryness or burning, and pain during sexual intercourse) and the lower urinary tract (increased frequency of urination, urgency to urinate, and pain while urinating). About half of postmenopausal women experience genitourinary syndrome, which does not improve without treatment.
How the review was done
The researchers did a systematic review of studies that were published up to April 2013.
They found 44 studies.
Key features of the studies were:
- the treatment was vaginal estrogen delivered by tablet, cream, gel, ring, ovule, or suppository;
- vaginal estrogen was compared with placebo or no treatment (14 studies with 4,232 women), another vaginal estrogen, systemic estrogen, nonhormonal moisturizer or lubricant, or other treatments; and
- studies were 1 month to 1 year long.
What the researchers found
The quality of evidence varied. Findings for comparisons and outcomes that are based on moderate-strength evidence are reported here. Evidence of poor, low, or very low-quality is not reported here.
Compared with placebo or no treatment, vaginal estrogen:
- reduced the frequency of urinary tract infections;
- reduced vaginal dryness, itching or burning, and painful intercourse;
- reduced urinary incontinence; and
- did not increase risk for side effects.
In women who have genitourinary syndrome of menopause, vaginal estrogens reduce symptoms and do not cause side effects.
Effects of vaginal estrogen compared with placebo or no treatment on genitourinary syndrome symptoms in menopausal women
Urinary tract infection
4 studies found that frequency of urinary tract infections was decreased with estrogen
Vaginal dryness, itching or burning, and painful intercourse
9 studies found that dryness improved with estrogen (2 found it did not)
6 studies found that itching or burning improved with estrogen (5 found it did not)
9 studies found that painful intercourse improved with estrogen (1 found it did not)
Urgency urinary incontinence
3 studies found that urgency urinary incontinence improved with estrogen
13 trials reported no difference in adverse events between women treated with estrogen and women treated with placebo
A harmless, inactive, and simulated treatment.
A comprehensive evaluation of the available research evidence on a particular topic.
Related Evidence Summaries
Cochrane Database of Systematic Reviews (2011)
Cochrane Database Syst Rev (2016)
Cochrane Database of Systematic Reviews (2013)
Related Web Resources
This patient decision aid helps women who have decided to treat their uterine fibroids decide on whether or not to have uterine fibroid embolization by comparing the benefits, risks, and side effects of both options. It also outlines alternative treatments such as over-the-counter pain medicine, hormones, or surgery.
This patient decision aid helps women with stress incontinence decide on whether or not to have surgery by comparing the benefits, risks, and side effects of both options. Alternative options to surgery include trying exercises, medicines, and medical devices.
This patient decision aid helps adult women decide on non surgical treatment choices for urinary incontinence. It outlines options such as lifestyle changes, exercises, medical devices, medicine, and bladder training and compares the benefits, risks and side effects associated with each option.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal